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A loop-mediated isothermal amplification (LAMP) assay targeting uvrC of Mycoplasma bovis was 
developed and evaluated. The assay specifically amplified only M. bovis; no cross-reactivity was 
observed for other Mycoplasma species or respiratory bacterial species. The sensitivity of the assay in 
pure cultures was 10-fold higher than that of polymerase chain reaction (PCR), with a detection limit of 
34 CFU per reaction. The accuracy of the assay was further validated by both restriction analysis and 
nucleotide sequencing of the amplified product. The assay was applied to 98 specimens collected from 
cattle with respiratory disease or from healthy individuals and compared with a PCR-based assay. The 
sensitivity and specificity of the LAMP assay in terms of PCR was 100 and 74%, respectively. In 
conclusion, we successfully developed a rapid, specific, and sensitive LAMP test for M. bovis detection 
in a clinical setting.  
 






Mycoplasma bovis is an important but sometimes 
overlooked cattle pathogen. It causes major economic 
losses mainly by causing pneumonia, arthritis, and 
reduced weight gain in calves; mastitis in cows; and 
reproductive problems in both cows and bulls (Tenk et al., 
2006; Caswell and Archambault, 2007). It is found 
worldwide and has spread into Africa, including Sudan 
(Abbas, 1996), Morocco (Taoudi et al., 1988) and the 
Republic of South Africa (Gilbert and Oettlé, 1990). 
Because M. bovis is largely unresponsive to antibiotic 
treatment, and because co-infection with other pathogens 
during subsequent stages make treatment more difficult 
(Nicholas and Ayling, 2003), a rapid, reliable, and 
practical diagnosis is essential for effective M. bovis 
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The   diagnosis   of   M.   bovis    infection   is  generally  
determined by culture, serologic, and molecular methods. 
Culture and metabolism-based assays are both time-
consuming and complex. In addition, the isolation of M. 
bovis from chronically ill animals is sometimes difficult 
because antibiotic treatment or secondary infections can 
inhibit isolation (Cai et al., 2005; Tenk et al., 2006). 
Serological methods are insufficiently sensitive, and 
cross-reactions with other Mycoplasma species can 
result in doubtful serological test results (Ghadersohi et 
al., 2005; Rosengarten et al., 1994). Molecular methods 
such as conventional polymerase chain reaction (PCR), 
multiplex PCR, and real-time PCR have been used to 
detect M. bovis (Cai et al., 2005; Foddai et al., 2005; 
Sung et al., 2006). Although, PCR-based assays for M. 
bovis are rapid and precise, they require agarose gel 
electrophoresis, which is time-consuming and tedious 
(Yamazaki et al., 2008). Real-time PCR assays are faster 
and involve less handling of the products compared with 
conventional PCR assays; however, because of an 
expensive thermal cycle with a fluorescence detector, this 
application is still not very common (Saito et al., 2005).  




Table 1. Bacteria and results of the LAMP assay. 
 
Organism Strain LAMP result 
Mycoplasma bovis HB0801, clinical isolates (n = 19) + (20/20) 
Mycoplasma agalactiae ATCC 35890, CVCC 344 - (0/2) 
Mycoplasma arginini  CVCC 346 - (0/1) 
Mycoplasma ovipneumoniae  ATCC 29419 - (0/1) 
Mycoplasma mycoides subsp. Capri CVCC 368  - (0/1) 
Mycoplasma gallisepticum Clinical isolate - (0/1) 
Bacillus anthracis Clinical isolate - (0/1) 
Escherichia coli Clinical isolate (n = 2) - (0/2) 
Mycobacterium bovis  ATCC BAA-935 - (0/1) 
Streptococcus pneumoniae Clinical isolates (n = 2) - (0/2) 
Staphylococcus aureus ATCC 25923, clinical isolate - (0/2) 
Mannheimia haemolytica Clinical isolate - (0/1) 
Pasteurella multocida Clinical isolate (n = 5) - (0/5) 
Salmonella typhimurium  ATCC 14028  - (0/1) 
Arcanobacterium pyogenes Clinical isolate - (0/1) 
Bacillus proteus Clinical isolate - (0/1) 
 
+, positive reaction; -, negative reaction (positive number/number of strains tested); ATCC, American Type Culture 




Loop-mediated isothermal amplification (LAMP) can 
amplify DNA with high specificity, efficiency, and speed 
under simple laboratory conditions (Notomi et al., 2000). 
It is conducted under isothermal conditions of appro-
ximately 60°C. Moreover, LAMP products can be 
detected not only by electrophoresis and staining, but 
also by visual observation of turbidity or fluorescence 
(Saito et al., 2005). The LAMP assay was initially 
evaluated for the detection of hepatitis B viral DNA 
(Notomi et al., 2000). Although the LAMP assay was 
recently applied to the direct detection of Campylobacter 
fetus (Yamazaki et al., 2009), M. bovis (Zhang et al., 
2011), and Riemerella anatipestifer (Zheng et al., 2011), 
no assay for the detection of M. bovis has been 
described. Here, we describe a rapid and simple LAMP 
assay for the detection of M. bovis. We evaluated the 
efficacy of this LAMP assay in the direct detection of 
specimens obtained from cattle. 
 
 
MATERIALS AND METHODS 
 
Bacterial strains and culture conditions 
 
A total of 43 strains were prepared for the evaluation of primer 
specificity (Table 1). M. bovis strain HB0801, which was used for 
standardization of the LAMP assay, was isolated from local cattle 
with respiratory disease, identified by chemical testing and genomic 
sequencing, and confirmed by the China Center for Type Culture 
Collection. The Mycoplasma species were cultured in Hayflick liquid 
medium supplemented with 10% (v/v) donor equine serum 
(HyClone, Logan, UT, USA) and penicillin (final concentration 800 
IU/ml) in an atmosphere of 5% CO2 at 37°C. M. bovis was grown in 
7H9 (BD, Franklin Lakes, NJ, USA) liquid culture in a biosafety level 




A total of 98 specimens were examined. 59 samples (51 nasal 
swabs, 2 tracheal swabs, and 6 lung samples) were collected from 
cattle suspected of having M. bovis infection. In addition, 15 nasal 
samples were collected from healthy cattle. Both specimens were 





Oligonucleotide primers targeting uvrC (GenBank accession no. 
AF003959) for LAMP were designed using LAMP primer design 
software (http://primerexplorer.jp/e/index.html). The 2 outer primers 
were designated as forward outer primer (F3) and backward outer 
primer (B3). The inner primers were designated as forward inner 
primer (FIP) and backward inner primer (BIP). FIP consisted of the 
complementary sequence of F1 (F1C) and sense sequence of F2. 
F1C contained an AluI restriction enzyme site. BIP consisted of the 
complementary sequence of B1 (B1C) and sense sequence of B2. 
The final locations of the primers were from 1,775 to 1,983 nt within 
uvrC; the sequences of the primers used for the amplification of M. 
bovis are shown in Table 2 and Figure 1. The sequences of the 





DNA for LAMP and PCR were prepared according to Mohran’s 
method with a slight modification (Mohran et al., 1998). DNA from 
pure cultures was extracted with the use of a boiling water bath for 
10 min, immediately placed in an ice bath for 2 min, and centrifuged 
at 13,000 × g for 1 min. In addition, 1 ml of sterilized phosphate-
buffered saline (PBS) was added to each nasal or tracheal swab 
and vortexed for 5 to 10 min. Lung tissue (0.5 g) was excised from 
the lesion edges, and 1 ml of sterile PBS was added to the tissue 
and homogenized with glass homogenizers. The supernatant from 
the swabs or lung tissue was filtered through a 0.45 µm filter 
membrane. The filtrate  was  sequentially  centrifuged  for  5 min  at  




Table 2. Sequences of the primers used in this study. 
 















Figure 1. Oligonucleotide primers used for the LAMP assay of M. bovis targeting uvrC. The arrowed letters indicate the 




13,000 × g for 30 min, and the pellet was dissolved in 50 µl of 
sterile PBS. It was then subjected to a boiling water bath, ice bath, 
and centrifugation as described above. The final supernatant 





The LAMP reaction was carried out in a 25 l reaction volume. The 
system contained 1.4 M betaine (Sigma, St. Louis, MO, USA), 200 
M dNTPs (TransGen Biotech), 2.5 l of 10× Bst buffer (20 mM 
Tris-HCl, 10 mM KCl, 10 mM [NH4]2SO4, 2 mM MgSO4, and 0.1% 
TritonX-100 [pH 8.8]), 8 U of Bst DNA polymerase large fragment 
(New England Biolabs), 0.64 M each of FIP and BIP, 0.08 M 
each of F3 and B3, and 1 l of template DNA. The reaction mixture 
was incubated in a heating block. Amplification was performed at 
58°C for 60 min followed by heating at 80°C for 5 min to terminate 
the reaction.  
 
 
Analysis of the LAMP products 
 
The products of the LAMP reaction were detected either as ladder-
like patterns using 2% agarose gel electrophoresis or by direct 
visualization of a color change after SYBR Green I staining. The 
solution turned green in the presence of a LAMP amplicon and 
remained orange without any amplification. The accuracy of the 
reaction was confirmed by restriction endonuclease digestion with 
AluI (a restriction site was present in F1); the predicted fragment 
sizes were 87 and 130 bp. In addition, the structures of the 
amplified products were confirmed by direct sequencing. 
Determination of the sensitivity of the LAMP assay 
 
To compare the sensitivity of the LAMP and PCR assays, M. bovis 
HB0801 was diluted serially 10-fold to a final concentration of 3.4 × 
106 to 3.4 × 100 CFU/l. A total of 1 ml of the bacteria for each 
dilution was boiled for 10 min, immediately placed in an ice bath for 
2 min, and centrifuged at 13,000 × g. Next, 1 l of the supernatant 
for each dilution was used as the template for amplification. 
Sensitivity tests of the LAMP and PCR assays were conducted in 




Determination of the specificity of the LAMP assay 
 
To determine the specificity of the method, the LAMP assay was 
carried out under the conditions described above using DNA from 
different bacteria (Table 1). The assay was carried out in triplicate. 
For further confirmation, the LAMP products were digested with 5 U 
of AluI. The original amplicon and digested products were subjected 





A PCR assay targeting uvrC was performed in a 20 l reaction 
volume containing 0.4 M each of UVRC1 and UVRC2, 1 U of 
TaqMix DNA polymerase, and 1 l of template DNA. Amplification 
was achieved under the following conditions: 95°C for 5 min 
followed by 30 cycles of 95°C for 1 min, 55°C for 1 min, and 7°C for 
30 s. A final extension was done  at  72°C  for  10  min. The  238 bp 






Figure 2. (A) Electrophoretic analysis of the LAMP products. Lane M, DL 2000 DNA marker; 
Lanes 1 and 3, repeated positive amplification of M. bovis HB0801 by LAMP assay; Lanes 2 
and 4, repeated AluI digestion of the LAMP products for the positive samples into 2 bands of 87 
and 130 bp. (B) Visual appearance of the LAMP reactions after the addition of SYBR Green I. 









Specificity of the LAMP assay 
 
A total of 43 known bacterial strains were analyzed to 
evaluate the specificity of the LAMP assay. By 
observation of SYBR Green I, uvrC was detected in all 20 
M. bovis strains, and no cross-reactivity was observed for 
other Mycoplasma species or respiratory bacterial 
species (Table 1). Furthermore, the LAMP products were 
subjected to 2% agarose gel electrophoresis, and a 
characteristic ladder of multiple bands was observed 
(Figure 2A). The amplified product was digested using 
AluI, and the fragment sizes were in good agreement with 
the sizes predicted from the expected DNA structures 
(Figure 2A). In addition, the sequence obtained matched 




Sensitivity of the LAMP assay 
 
To ascertain the detection limit of our LAMP assay for M. 
bovis, serial 10-fold dilutions of M. bovis HB0801 were 
tested by LAMP and PCR. Our results show a detection 
limit of 3.4 × 101 CFU per reaction for LAMP and 3.4 × 
102 CFU per reaction for PCR. Thus, LAMP was 10-fold 
more sensitive than PCR. Amplification by LAMP showed 
a ladder-like pattern, whereas PCR produced a 238 bp 
amplicon, which is equal to the expected length of the 
gene fragment (Figure 3). 
 
 
Evaluation of the LAMP assay using clinical 
specimens 
 
The LAMP assay was evaluated for the ability to detect 
M. bovis in clinical specimens using 98 samples from 
cattle, and the results were compared with those obtained 
using PCR (Table 3). The specificity of the LAMP assay 
was further confirmed by restriction analysis as well as 
nucleotide sequencing of the amplified product (data not 
shown). The LAMP assay detected 54 positive samples 
and 44 negative samples; the PCR assay detected 29 
positive samples and 69 negative samples. Of the 98 
samples, 29 were positive and 44 were negative by both 
tests. However, the LAMP assay was able to detect M. 
bovis DNA in 25 additional specimens that were negative 
by PCR. The sensitivity and specificity of the LAMP assay 
in terms of PCR was 100  and  74%,  respectively.  Of  51  






Figure 3. Sensitivity of the electrophoretic analysis of (A) LAMP- and (B) PCR-amplified products. Lane M, DL 2000 DNA 
marker; Lane 1, genomic DNA from 3.4 × 106 CFU of M. bovis; Lane 2, 3.4 × 105; Lane 3, 3.4 × 104; Lane 4, 3.4 × 103; 




Table 3.  Comparative evaluation of LAMP and PCR for the detection of M. bovis in clinical specimens. 
 
Specimen type Number of sample tested 
% (number) of positive sample for assay 
LAMP PCR 
Nasal swabs 51 90 (46) 45 (23) 
Lung tissue 6 100 (6) 67 (4) 
Tracheal swabs 2 100 (2) 100 (2) 
Healthy nasal swabs 39 0 0 




nasal swabs, 90% (46/51) were positive by LAMP 
compared to 45% (23/51) positive by PCR. Of 6 lung 
tissue samples, 100% (6/6) were positive by LAMP 
compared to 67% (4/6) positive by PCR. Two tracheal 
swabs were positive by LAMP and PCR. None of the 
healthy nasal swabs tested were positive, indicating the 





In this study, we developed a novel LAMP assay for the 
rapid detection of M. bovis in culture isolates or clinical 
specimens. LAMP is a simple diagnostic tool in which the 
reaction takes place in a single tube. The primers, buffer, 
and DNA polymerase are mixed together, and the 
mixture is incubated in a regular laboratory water bath or 
heat block that provides a constant temperature (Saito et 
al., 2005). The culture and identification of M. bovis takes 
3-10 days to produce results (Cai et al., 2005). 
Conventional PCR assays require 4 to 5 h for 
amplification, electrophoresis, and staining. The overall 
time required for DNA extraction from samples and 
amplification using the LAMP assay is approximately 1 h. 
Further, amplification by the LAMP assay can be judged 
by direct visual assessment without the need for 
electrophoresis (Yamazaki et al., 2008; Inácio et al., 
2008). The LAMP assay was found to be quicker and 
simpler than conventional culture or PCR. 
In the present study, the assay specifically amplified 
only M. bovis; no cross-reactivity was observed for other 
Mycoplasma species or other respiratory bacterial 
species. These results demonstrate the highly efficient 
detection and strong specificity for the amplification of M. 
bovis. The efficiency of amplification was 34 CFU per 
reaction, which is more than 10 times that of conventional 
PCR.  
A total of 74 specimens were tested simultaneously by 
LAMP and PCR, and the positive detection rates for 
LAMP (55%) were much higher than those for PCR 
(30%). Moreover, M. bovis was detected among the 
various types of clinical specimens. These results 
demonstrate that LAMP is the most sensitive method and 
can meet the requirement for speed in the clinical field.  
LAMP primers were designed for this assay in a highly 
conserved region of the M. bovis uvrC gene. In a 
previous study, Subramaniam et al. (1998) established a 
PCR assay using uvrC and demonstrated that it clearly 
differentiated M. bovis and M. agalactiae. Thomas et al. 
(2004) used PCR to amplify the uvrC gene of 92 strains, 
sequenced 20 of them, and confirmed that uvrC is a 
suitable target for the diagnosis of M. bovis using PCR.  




The strong sensitivity and specificity obtained in the 
present study further confirmed that uvrC is a suitable 
conserved target for the diagnosis of M. bovis using 
LAMP. 
The exquisite sensitivity of the LAMP method makes it 
vulnerable to contamination. Controls are necessary in 
LAMP procedure. In addition, a pre-incubation of the 
multiplex LAMP reaction mix with UNG could prevent 
LAMP products from carry-over contamination effectively 
(He and Xu, 2011). More studies on preventing the carry-
over contamination in the process of LAMP should be 
explored. 
In conclusion, a LAMP assay was developed and 
evaluated for the detection of M. bovis, and it was found 
to be markedly more sensitive, specific, and rapid than 
conventional PCR. The assay can be carried out in a 
local laboratory without the need for specialized equip-
ment. Additional studies of larger numbers of clinical 
samples of different types are needed before it can be 
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